If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Share News (APH)

  • This share is currently suspended. It was suspended at a price of 64.70
  • There is currently no data for APH

Alliance Pharma exec offloads 300,000 shares

Mon, 20th Jan 2014 15:49
Speciality drugs firm Alliance Pharma announced Monday that Executive Director Anthony Booley's share in the company was reduced by 300,000 shares after his wife Lynette sold a portion of her stake. Booley, who joined the company in 1998, and his wife earned £100,500 from the sale after disposing of the shares at 33.50p a piece. The transaction was made on Friday, just a few days after the company revealed it would hit its profit expectations for 2013.Alliance said annual turnover was expected to hit £45.5m, up marginally from the £44.9m of the year before, with pre-tax profits in line with current market expectations.The company also announced the acquisition on Tuesday of rights to thyroid product Irenat from Germany's Bayer, in addition to December's acquisition of popular lip balm Lypsyl.Based on the latest full-year sales figures, Lypsyl adds around £1.2m of annual revenue with Irenat bringing a further 0.8m euro. Despite the positivity of the statement, broker Investec issued a 'sell' recommendation on the shares, saying: "Although the company is cash generative and has debt facilities to provide firepower for acquisitions, we think these will be required to support current forecasts. This, alongside our valuation model indicating that the shares look over-rated, suggests it is time to take profits." Booley's share sale did little to boost sentiment, with the share price falling 2% on Monday. Top Director BuysFalkland Islands Holdings (FKL) Director name: Mr John Laurence FosterAmount purchased: 10,000 @ 338.00p Value: £33,800North Atlantic Smaller Companies Inv Trust (NAS) Director name: Mr Christopher H B MillsAmount purchased: 2,000 @ 1,575.00p Value: £31,500Majestic Wine (MJW) Director name: Mr Ian HardingAmount purchased: 5,000 @ 500.00p Value: £25,000Top Director SellsITE Group (ITE) Director name: Mr Neil JonesAmount sold: 42,000 @ 311.00p Value: £130,620Alliance Pharma (APH) Director name: Mr Tony BooleyAmount sold: 300,000 @ 33.50p Value: £100,500First Derivatives (FDP) Director name: Mr David AndersonAmount sold: 2,500 @ 1,356.00p Value: £33,900NR

Related News

IN BRIEF: North Atlantic Smaller Cos Trust books Coventbridge return
3 days ago

IN BRIEF: North Atlantic Smaller Cos Trust books Coventbridge return

North Atlantic Smaller Cos Investment Trust PLC - invests in public and private smaller companies based in countries bordering the North Atlantic - Ma...

IN BRIEF: Aquila European adds North Atlantic Smaller CEO to board
21 May 2026

IN BRIEF: Aquila European adds North Atlantic Smaller CEO to board

Aquila European Renewables PLC - currently in a managed wind-down, had previously invested in European renewable energy assets - Appoints Christopher ...

Alliance Pharma News

Alliance Pharma loss narrows in 2024 due to reduced impairment charges
8 Apr 2025

Alliance Pharma loss narrows in 2024 due to reduced impairment charges

(Alliance News) - Alliance Pharma PLC on Tuesday reported a narrowed loss for 2024 despite a decline in revenue, due to a reduction in impairment char...

Alliance Pharma confident despite softer sales
8 Apr 2025

Alliance Pharma confident despite softer sales

(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.

Alliance Pharma board backs final GBP362 million takeover bid
10 Mar 2025

Alliance Pharma board backs final GBP362 million takeover bid

(Alliance News) - Alliance Pharma PLC on Monday said it has agreed to a final increased cash offer of 64.75 pence per share from Dbay Advisors Ltd and...

Alliance Pharma agrees to take-private deal
10 Mar 2025

Alliance Pharma agrees to take-private deal

(Sharecast News) - Speciality drugmaker Alliance Pharma has agreed to be taken private in a deal valued at more than £360.0m.

Alliance Pharma expects to post flat annual profit, revenue decline
31 Jan 2025

Alliance Pharma expects to post flat annual profit, revenue decline

(Alliance News) - Alliance Pharma PLC on Friday said it expects to report 2024 profit broadly in line with the year before, despite a decline in annua...

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next
31 Jan 2025

LONDON BROKER RATINGS: Jefferies likes Volex; UBS raises Next

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: